The CYP1B1, KMO, and TDO2 genes with a risk ratio greater than 1 were classified as risk factors for ccRCC, whereas the remaining 19/24 genes were considered protective factors (Fig. 2F). This evidence concerns the gene TDO2 and nonpapillary renal cell carcinoma.